Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea
Permanent neonatal diabetes (PNDM) can result from activating heterozygous mutations in KCNJ11 gene, encoding the Kir6.2 subunit of the pancreatic ATP-sensitive potassium channels (KATP). Sulfonylureas promote KATP closure and stimulate insulin secretion, being an alternative therapy in PNDM, instead of insulin. Male, 20 years old, diagnosed with diabetes at 3 months of age. The genetic study identified a novel heterozygous mutation in exon 1 of the KCNJ11 gene – KCNJ11:c1001G>7 (p.Gly334Val) – and confirmed the diagnosis of PNDM. Therefore it was attempted to switch from insulin therapy to sulfonylurea. During glibenclamide institution C-peptide levels increased, however the suboptimal glycemic control lead us to restart an intensive insulin scheme. This new variant of KCNJ11 mutation had a phenotypic lack of response to sulfonylurea therapy. Age, prior poor metabolic control and functional change of KATP channel induced by this specific mutation may explain the observed unsuccessful switch to sulfonylurea. Interestingly, C-peptide levels raise during glibenclamide administration support some degree of improvement in insulin secretory capacity induced by the treatment. Understanding the response to sulfonylurea is crucial as successful treatment may be life-changing in these patients.
Main Authors: | Lau,Eva, Correia,Cintia, Freitas,Paula, Nogueira,Claúdia, Costa,Maria, Saavedra,Ana, Costa,Carla, Carvalho,Davide, Fontoura,Manuel |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Endocrinologia e Metabologia
2015
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000600559 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene
by: Vendramini,Marcio F., et al.
Published: (2010) -
Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene
by: Della Manna,Thais, et al.
Published: (2008) -
Interactions of two sulfonylurea herbicides with organoclays
by: Carrizosa, M. J., et al.
Published: (2004) -
Unsuccessful treatment of sideroblastic anaemia with chloroquine
by: Lima,Carmen S. P., et al.
Published: (2003) -
Herbicide management in glyphosate and sulfonylurea-tolerant soybeans
by: Silva,André Felipe Moreira, et al.
Published: (2020)